<?xml version='1.0' encoding='utf-8'?>
<document id="26391788"><sentence text="Potential drug-drug interactions in oncological adult inpatients at a Spanish hospital: epidemiology and risk factors." /><sentence text="Oncological patients are at high risk for drug-drug interactions (DDIs), which may contribute to therapeutic failure or lead to serious adverse events" /><sentence text="" /><sentence text="To determine the prevalence of potential DDIs in medication lists, to describe the most frequent DDIs and to investigate the possible risk factors associated with them" /><sentence text=" A prospective cohort study was performed at the Oncology Department of a tertiary hospital over a 12-week period" /><sentence text=" Twice a week, every inpatient's treatment sheet was collected and screened through two databases: Micromedex™ and Drug Interaction Facts™" /><sentence text=" All identified potential DDIs with a moderate or higher severity rating were recorded" /><sentence text=" Multivariate analysis was used to identify risk factors associated with DDIs" /><sentence text="" /><sentence text="A total of 1956 DDIs were detected in 699 treatment sheets" /><sentence text=" The prevalence of treatment sheets with DDIs was 81" /><sentence text="0 % and 32" /><sentence text="6 % by Micromedex™ and Drug Interaction Facts™, respectively" /><sentence text=" Central nervous depressant agents and antiemetics were the most commonly involved groups in DDIs" /><sentence text=" A higher number of non-antineoplastic drugs was related with potential DDIs [adjusted-OR 1" /><sentence text="398 and 1" /><sentence text="613 by Micromedex™ and Drug Interaction Facts™, respectively]" /><sentence text=" CONCLUSION The prevalence of potential DDIs was widely variable among databases" /><sentence text=" The main risk factor associated with DDIs was a higher number of non-antineoplastic medicines" /><sentence text="" /></document>